Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

2:56pm EDT
Price Change (% chg)

$1.56 (+3.14%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ALKS.O


Alkermes Public Limited Company is an integrated, global biopharmaceutical company. The Company has a portfolio of more than 20 commercial drug products and a clinical pipeline of product candidates that address central nervous system (CNS) disorders such as addiction, schizophrenia and depression. The Company manufactures... (more)


Beta: 1.13
Market Cap (Mil.): $7,234.52
Shares Outstanding (Mil.): 145.83
Dividend: --
Yield (%): --


  ALKS.O Industry Sector
P/E (TTM): -- 170.49 34.41
EPS (TTM): -0.07 -- --
ROI: -0.65 -1.91 17.37
ROE: -0.88 -7.10 18.18
Search Stocks

Even with Irish address, Alkermes prefers independence

SAN DIEGO - Dublin, Ireland-based Alkermes Plc has the low-tax domicile currently in vogue among multinational pharmaceutical companies but is not interested in being bought out as it nears the launch of new drugs, its chief executive said on Monday.

23 Jun 2014


Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.
Provider: S&P Capital IQ – STARS Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks